PeptiDex is an independent research reference. We are not a pharmacy, clinic, or medical provider. We do not sell, ship, or handle controlled substances. We provide educational reference material for researchers studying peptide pharmacology. All efficacy claims attributed to published peer-reviewed sources.
"The Gut Healer"
Gut healing, IBD relief, reduced intestinal inflammation, mucosal repair
BPC-157's tissue repair meets KPV's potent NF-κB suppression. BPC-157 heals the physical damage while KPV turns off the inflammatory signaling causing it. The ultimate gut restoration protocol.
BPC-157 promotes GI mucosal healing via cytoprotective pathways and angiogenesis. KPV (alpha-MSH fragment) powerfully suppresses NF-κB inflammatory signaling and reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in intestinal epithelium.
Typical Ratio: BPC-157 500mcg + KPV 200-500mcg
BPC-157 250-500mcg SubQ + KPV 200-500mcg orally or SubQ. KPV oral capsules target gut directly. Cycle 4-12 weeks.
Week 1
Rapid reduction in gut inflammation; improved GI comfort
Weeks 2–4
Mucosal healing; reduced bloating and IBS/IBD symptoms
Months 2–3
Significant GI restoration; normalized bowel function
Long-term
Sustained gut health; potential remission of chronic GI conditions
Both peptides have excellent safety profiles. KPV can be taken orally for gut-specific effects. Not FDA-approved.
Research use only. Not FDA-approved for the combination described. Consult a qualified healthcare provider before use.